Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Botanical Resources Australia (BRA) is a world-leading producer of natural pyrethrum, a botanical insecticide extracted from the Dalmatian chrysanthemum (Tanacetum cinerariifolium). Based in Tasmania, the company operates a vertically integrated business model that encompasses plant breeding, agricultural production, and advanced extraction and refining processes. Their high-quality pyrethrins are supplied globally for use in household pest control, professional turf management, and public health programs to combat disease-carrying insects. In 2017, BRA was acquired by Sumitomo Chemical, strengthening its position within the global environmental health and crop protection markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Botanical Resources Australia.